Deka Bank Deutsche Girozentrale Bio Rad Laboratories, Inc. Transaction History

Deka Bank Deutsche Girozentrale

  • $54.1 Billion
  • Q4 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 12,211 shares of BIO stock, worth $3.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,211
Previous 12,211 -0.0%
Holding current value
$3.84 Million
Previous $4.03 Million 1.31%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$263.97 - $344.64 $891,162 - $1.16 Million
-3,376 Reduced 21.66%
12,211 $4.03 Million
Q2 2024

Aug 08, 2024
BUY
$268.26 - $339.48 $872,381 - $1.1 Million
3,252 Added 26.36%
15,587 $4.23 Million
Q1 2024

Apr 24, 2024
SELL
$304.11 - $351.99 $277,956 - $321,718
-914 Reduced 6.9%
12,335 $4.3 Million
Q4 2023

Jan 24, 2024
SELL
$269.37 - $365.04 $24,782 - $33,583
-92 Reduced 0.69%
13,249 $4.25 Million
Q3 2023

Nov 13, 2023
BUY
$350.25 - $422.63 $1.51 Million - $1.83 Million
4,325 Added 47.97%
13,341 $4.74 Million
Q2 2023

Jul 25, 2023
SELL
$359.49 - $486.4 $200,954 - $271,897
-559 Reduced 5.84%
9,016 $3.38 Million
Q1 2023

Apr 24, 2023
SELL
$418.69 - $503.0 $158,683 - $190,637
-379 Reduced 3.81%
9,575 $4.48 Million
Q4 2022

Feb 01, 2023
BUY
$351.71 - $456.01 $694,978 - $901,075
1,976 Added 24.77%
9,954 $4.21 Million
Q3 2022

Nov 02, 2022
BUY
$412.59 - $563.26 $105,623 - $144,194
256 Added 3.32%
7,978 $3.31 Million
Q2 2022

Aug 03, 2022
SELL
$463.67 - $597.16 $469,234 - $604,325
-1,012 Reduced 11.59%
7,722 $3.76 Million
Q1 2022

Apr 28, 2022
SELL
$524.57 - $735.42 $22,556 - $31,623
-43 Reduced 0.49%
8,734 $5.06 Million
Q4 2021

Feb 02, 2022
SELL
$708.84 - $794.68 $329,610 - $369,526
-465 Reduced 5.03%
8,777 $6.62 Million
Q3 2021

Oct 22, 2021
BUY
$657.71 - $825.77 $21,046 - $26,424
32 Added 0.35%
9,242 $6.91 Million
Q2 2021

Aug 05, 2021
SELL
$576.64 - $649.04 $69,196 - $77,884
-120 Reduced 1.29%
9,210 $5.84 Million
Q1 2021

Apr 28, 2021
BUY
$547.01 - $662.35 $263,658 - $319,252
482 Added 5.45%
9,330 $5.24 Million
Q4 2020

Mar 12, 2021
SELL
$510.68 - $643.45 $1.67 Million - $2.11 Million
-3,275 Reduced 27.01%
8,848 $5.07 Million
Q3 2020

Oct 29, 2020
BUY
$454.43 - $535.6 $266,750 - $314,397
587 Added 5.09%
12,123 $6.14 Million
Q2 2020

Aug 04, 2020
BUY
$334.87 - $493.06 $640,941 - $943,716
1,914 Added 19.89%
11,536 $5.03 Million
Q1 2020

May 14, 2020
SELL
$320.01 - $409.07 $204,486 - $261,395
-639 Reduced 6.23%
9,622 $3.32 Million
Q4 2019

Feb 04, 2020
BUY
$319.73 - $374.2 $347,866 - $407,129
1,088 Added 11.86%
10,261 $3.75 Million
Q3 2019

Nov 14, 2019
SELL
$304.55 - $345.24 $219,276 - $248,572
-720 Reduced 7.28%
9,173 $3.08 Million
Q2 2019

Aug 01, 2019
BUY
$286.93 - $312.59 $586,197 - $638,621
2,043 Added 26.03%
9,893 $3.05 Million
Q1 2019

May 10, 2019
SELL
$224.3 - $317.41 $67,290 - $95,223
-300 Reduced 3.68%
7,850 $2.56 Million
Q4 2018

Feb 12, 2019
BUY
$220.1 - $309.0 $66,030 - $92,700
300 Added 3.82%
8,150 $1.88 Million
Q2 2018

Aug 14, 2018
SELL
$244.1 - $303.88 $146,460 - $182,328
-600 Reduced 7.1%
7,850 $2.28 Million
Q1 2018

May 03, 2018
SELL
$233.97 - $274.11 $269,065 - $315,226
-1,150 Reduced 11.98%
8,450 $2.11 Million
Q3 2017

Nov 06, 2017
BUY
$212.27 - $242.28 $2.04 Million - $2.33 Million
9,600
9,600 $2.06 Million

Others Institutions Holding BIO

# of Institutions
467
Shares Held
18.8M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.75B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email